Phillip Callihan
Overview
Explore the profile of Phillip Callihan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Callihan P, Alqinyah M, Hooks S
Methods Mol Biol
. 2017 Apr;
1697:141-151.
PMID: 28361481
Sphingosine-1-phosphate (S1P) and its receptors are important in nervous system development. Reliable in vitro human model systems are needed to further define specific roles for S1P signaling in neural development....
2.
Callihan P, Ali M, Salazar H, Quach N, Wu X, Stice S, et al.
ASN Neuro
. 2014 Nov;
6(6).
PMID: 25424429
The bioactive lysophospholipids lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) have diverse effects on the developing nervous system and neural progenitors, but the molecular basis for their pleiotropic effects is...
3.
Callihan P, Hooks S
Methods Mol Biol
. 2012 Apr;
874:193-200.
PMID: 22528449
Sphingosine-1-phosphate (S1P) and its receptors are important in nervous system development. Reliable in vitro human model systems are needed to further define specific roles for S1P signaling in neural development....
4.
Callihan P, Zitomer N, Stoeling M, Kennedy P, Lynch K, Riley R, et al.
Neuropharmacology
. 2011 Oct;
62(2):988-96.
PMID: 22016110
In vivo and in vitro studies suggest a crucial role for Sphingosine 1-phosphate (S1P) and its receptors in the development of the nervous system. Dihydrosphingosine 1-phosphate (dhS1P), a reduced form...
5.
Callihan P, Mumaw J, Machacek D, Stice S, Hooks S
Pharmacol Ther
. 2010 Nov;
129(3):290-306.
PMID: 21073897
Stem cell-based therapeutics have the potential to effectively treat many terminal and debilitating human diseases, but the mechanisms by which their growth and differentiation are regulated are incompletely defined. Recent...
6.
Hooks S, Callihan P, Altman M, Hurst J, Ali M, Murph M
Mol Cancer
. 2010 Nov;
9:289.
PMID: 21044322
Background: A critical therapeutic challenge in epithelial ovarian carcinoma is the development of chemoresistance among tumor cells following exposure to first line chemotherapeutics. The molecular and genetic changes that drive...
7.
Hurst J, Mumaw J, Machacek D, Sturkie C, Callihan P, Stice S, et al.
BMC Neurosci
. 2008 Dec;
9:118.
PMID: 19077254
Background: Lysophospholipids regulate the morphology and growth of neurons, neural cell lines, and neural progenitors. A stable human neural progenitor cell line is not currently available in which to study...